EGFR and non-small cell lung carcinoma: advanced (stage IIIB/IV or recurrent) non‐squamous EGFR‐mutated (ex19del or L858R mutation, without T790 M) NSCLC, age≥20 years, ECOG 0–1, no previous chemotherapy for advanced disease, without CNS metastases